Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)
Primary Purpose
Traveller's Fever
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Rectal Swab
Sponsored by
About this trial
This is an interventional diagnostic trial for Traveller's Fever
Eligibility Criteria
Inclusion Criteria:
- Patient admitted for traveller's fever requiring a microbiological examination with a "Traveller's fever POC kit"
- Patient who freely signed the informed consent form
- Patient affiliated to a social security regime
Exclusion criteria
- Pregnant or breastfeeding women
- Adult patient under guardianship
- Patient deprived with liberty under court order
- Patient refusing or unable to sign the informed consent form
Sites / Locations
- Assistance Publique Hopitaux de Marseille
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patients admitted for traveller's fever
Arm Description
Outcomes
Primary Outcome Measures
Percentage of patients admitted for traveller's fever with a confirmed etiological diagnosis
Secondary Outcome Measures
Full Information
NCT ID
NCT02868411
First Posted
August 11, 2016
Last Updated
April 20, 2023
Sponsor
Assistance Publique Hopitaux De Marseille
1. Study Identification
Unique Protocol Identification Number
NCT02868411
Brief Title
Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
June 11, 2013 (Actual)
Primary Completion Date
February 8, 2019 (Actual)
Study Completion Date
October 26, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of traveller's fever caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC traveller's fever tests .
The objective of this study is to implement a new diagnosis strategy relying on the hypothesis that a rectal swab would improve the etiological diagnosis of traveller's fever of at least 10%.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traveller's Fever
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
159 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients admitted for traveller's fever
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Rectal Swab
Primary Outcome Measure Information:
Title
Percentage of patients admitted for traveller's fever with a confirmed etiological diagnosis
Time Frame
1 day
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient admitted for traveller's fever requiring a microbiological examination with a "Traveller's fever POC kit"
Patient who freely signed the informed consent form
Patient affiliated to a social security regime
Exclusion criteria
Pregnant or breastfeeding women
Adult patient under guardianship
Patient deprived with liberty under court order
Patient refusing or unable to sign the informed consent form
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Catherine GEINDRE
Organizational Affiliation
Assistance Publique Hôpitaux de Marseille
Official's Role
Study Director
Facility Information:
Facility Name
Assistance Publique Hopitaux de Marseille
City
Marseille
Country
France
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)
We'll reach out to this number within 24 hrs